Uses: dolasetron mesylate is an anti emetic that was first developed successfully by Hoechst Marion Roussel, Germany, as a selective serotonin (5-HT3) receptor antagonist acting similarly to ondansetron and granisetron.
Properties
Summary
Dolasetron Mesylate acts as a bridged pseudopelletierine derivative; specific serotonin (5HT3) receptor antagonist. Antiemetic.